Prof. Lee P. Shulman
Northwestern
University, USA
Email:
lps5@cornell.edu
Qualifications
1983 Ph.D., Cornell University Medical
College, USA
1979 B.Sc., Cornell University, USA
Publications (selected)
-
Nikolic D,
Yuan Y, Wright B, Banuvar S,
Shulman LP, Van Breemen RB. LC-MS analysis of prenylated flavonoids from hops
in support of a Phase I clinical trial. American Society of Mass
Spectrometry, Denver, CO, 2011.
-
Shulman LP,
Banuvar S, Fong HHS, Farnsworth NR (2010). Discussion of a well-designed
clinical trial which did not demonstrate effectiveness: UIC Center for
Botanical Dietary Supplements Research Study of Black Cohosh and Red
Clover. Fitoterapia, Oct 27 (epub ahead of print).
-
Szarewski A,
Mansour D, Shulman LP (2010). 50 years of “The Pill”: celebrating a
golden anniversary. J Fam Plann Reprod Health Care, 36: 231-8.
-
Shulman LP
(2010). Gynecological management of premenstrual symptoms. Curr
Pain Headache Rep, DOI: 10.1007/s11916-010-0131-9.
-
Freeman S,
Shulman LP (2010). Considerations for the use of progestin-only
contraceptives. J Am Acad Nurse Pract, 22: 81-91.
-
Kiley J,
Shulman LP (2009). Cesarean scar ectopic pregnancy in a patient with
multiple prior cesarean sections: a case report. J Reprod Med, 54: 251-4.
-
Kaunitz AM,
Benrubi GI, Barbieri RL, Darney PD, Edelman A, Speroff L, Espey E, Shulman LP
(2009). Ethics and referral for abortion (Letter to the
Editor). Am J Obstet Gynecol, 200: e9.
-
Maki PM, Rubin
LH, Fornelli D, Drogos L, Banuvar S, Shulman LP, Geller SE. Effects
of botanicals and combined hormone therapy on cognition in midlife women. Menopause, Jul 31 epub.
-
Geller SE,
Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, Hedayat S, Nikolic D,
Krause EC, Piersen CE, Bolton JL, Pauli GF, Farnsworth NR (2009). Safety
and efficacy of black cohosh and red clover for the management of vasomotor
symptoms: a randomized controlled trial. Menopuase, Jul 15 epub.
-
Bryant-Borders
AE, Greenberg J, Plaga S, Shepard-Hinton M, Yates C, Elias S, Shulman LP
(2009). Use of amniocentesis prior to uterine evacuation to increase
the likelihood of obtaining cytogenetic outcomes in cases of second- and
third-trimester fetal demise. Fetal Diagn Ther, 26: 81-4.
-
van Breemen
RB, Liang W, Banuvar S, Shulman LP, Pang Y, Tao Y, Nikolic D, Krock KM,
Fabricant DS, Chen SN, Hedayat S, Bolton JL, Pauli GF, Piersen CE, Krause EC,
Geller SE, Farnsworth NR. Pharmacokinetics of 23-Epi-26-Deoxyactein in women
after oral administration of a standardized extract of Black Cohosh. Clin
Pharmacol Ther, 2009 Dec 23. [Epub ahead of print].
-
Grobman WA,
Auger M, Shulman LP, Elias S (2009). The association between
chorionic villus sampling and preeclampsia. Prenat Diagn, 29: 800–3.
-
Shulman LP,
Portman DJ, Lee WC, Balu S, Joshi AV, Cobden D, Wang Q, Pashos CL (2008). A
retrospective managed care claims data analysis of medication adherence to
vaginal estrogen therapy: implications for clinical practice. Journal
of Women’s Health, 17: 569-78.
-
Hoffman ML,
Scoccia B, Kurczynski TW, Shulman LP, Gao W (2008). Abnormal folate
metabolism as a risk factor for first-trimester spontaneous abortion. J
Reprod Med, 53(3): 207-12.
-
Maki PM,
Drogos LL, Rubin LH, Banuvar S, Shulman LP, Geller SE (2008). Objective
hot flashes are negatively related to verbal memory performance in midlife
women. Menopause, 15: 848-56.
-
Bahamondes L,
Cordova-Eguez S, Pons JE, Shulman L (2007). Perspectives on
Premenstrual Syndrome.Premenstrual Dysphoric Disorder. Dis Manage
Health Outcomes, 15: 263-77.
-
Simon M,
Shulman LP (2007). Alternatives to oral regimens of
contraception. Minerva Ginecologica, 59: 271-86.
-
Gabriel H,
Shulman LP, Marko J, Nikolaidis P (2007). Compound versus
fundamental imaging in the detection of subdermal contraceptive implants. J
Ultrasound Med, 26: 355-9.
-
Booth NL, Pierson CE, Banuvar S, Geller SE, Shulman LP, Farnsworth NR
(2006). Clinical studies of red clover (Trifolium
pratense) dietary supplements in menopause: a literature review. Menopause, 13: 251-64.
-
Shulman LP
(2006). A review of drospirenone for safety and tolerability and
effects on endometrial safety and lipid parameters contrasted with
medroxyprogesterone acetate, levonorgestrel, and micronized
progesterone. J Womens Health, 15: 584-90.
-
Creinin M, Blumenthal P, Shulman L (2006). Mifepristone-Misoprostol
Medical Abortion Mortality. Medscape General Medicine, 8(2): 26.
-
Bonnick SL,
Shulman L (2006). Monitoring osteoporosis therapy: bone mineral
density, bone turnover markers, or both? Am J Med, 119: 25S-31S.
-
Shulman LP
(2006). New recommendations for the periodic well-woman visit:
impact on counseling. Contraception, 73: 319-24.
-
Shulman LP,
Gabriel H (2006). Management and localization strategies for the
nonpalpable Implanon rod. Contraception, 73:325-30.
-
Stewart FH,
Kaunitz AM, LaGuardia KD, Karvois DL, Fisher AC, Friedman AJ and the ORTHO EVRA
Extended Regimen Study Group (Shulman LP, member) (2005). Extended
use of transdermal norelgestromin/ethinyl estradiol: A randomized trial. Obstetrics
and Gynecology, 105: 1389–96.
-
Shulman LP,
Shields W (2005). The expanding role of genetics in contraception
and women’s health. Contraception, 71: 81-3.